These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21111391)

  • 1. Addressing gaps in pharmacovigilance practices in the antiretroviral therapy program in the Eastern Cape Province, South Africa.
    Ruud KW; Srinivas SC; Toverud EL
    Res Social Adm Pharm; 2010 Dec; 6(4):345-53. PubMed ID: 21111391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral treatment and follow-up of HIV-infected patients by health care providers in South African public primary health care.
    Ruud KW; Toverud EL; Radloff S; Srinivas SC
    J Assoc Nurses AIDS Care; 2010; 21(5):417-28. PubMed ID: 20303798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India.
    Modayil RR; Harugeri A; Parthasarathi G; Ramesh M; Prasad R; Naik V; Giriyapura V
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):247-55. PubMed ID: 20066675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the paediatric HIV epidemic: a perspective from the Western Cape Region of South Africa.
    Eley B
    Trans R Soc Trop Med Hyg; 2006 Jan; 100(1):19-23. PubMed ID: 16154608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge of HIV and its treatment among health care providers in South Africa.
    Ruud KW; Srinivas SC; Toverud EL
    Int J Clin Pharm; 2014 Apr; 36(2):352-9. PubMed ID: 24366678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare providers' experiences with adverse drug reactions and adherence challenges in antiretroviral therapy of HIV patients in the Eastern Cape Province, South Africa.
    Ruud KW; Srinivas SC; Toverud EL
    Eur J Clin Pharmacol; 2012 Sep; 68(9):1321-8. PubMed ID: 22418830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of antiretrovirals in HIV-infected pregnant women.
    Zuk DM; Hughes CA; Foisy MM; Robinson JL; Singh AE; Houston S
    Ann Pharmacother; 2009 Jun; 43(6):1028-35. PubMed ID: 19491318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
    Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
    J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TB patients' perspectives on integrated TB/HIV services in South Africa.
    Levin L; Irving K; Dikgang M; Punwasi J; Isaacs M; Myer L
    Trop Doct; 2006 Jul; 36(3):173-5. PubMed ID: 16884629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring task-shifting practices in antiretroviral treatment facilities in the Free State Province, South Africa.
    de Wet K; Wouters E; Engelbrecht M
    J Public Health Policy; 2011; 32 Suppl 1():S94-101. PubMed ID: 21730997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing social preparedness for antiretroviral therapy in a generalized AIDS epidemic: a diffusion of innovations approach.
    Mitchell SK; Kelly KJ; Potgieter FE; Moon MW
    AIDS Behav; 2009 Feb; 13(1):76-84. PubMed ID: 17705035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "They (ARVs) are my life, without them I'm nothing"--experiences of patients attending a HIV/AIDS clinic in Johannesburg, South Africa.
    Gilbert L; Walker L
    Health Place; 2009 Dec; 15(4):1123-9. PubMed ID: 19596603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions associated with antiretroviral therapy in South Africa.
    Birbal S; Dheda M; Ojewole E; Oosthuizen F
    Afr J AIDS Res; 2016 Sep; 15(3):243-8. PubMed ID: 27681148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The knowledge and acceptance of the HIV prevention program in pregnant women in the Free State Province of South Africa.
    Griessel DJ; van der Vyver AE; Joubert G; Ludada G; Mogorosi J; Tau M; Thibile S
    J Trop Pediatr; 2010 Aug; 56(4):263-4. PubMed ID: 19948782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
    Boulle A; Van Cutsem G; Hilderbrand K; Cragg C; Abrahams M; Mathee S; Ford N; Knight L; Osler M; Myers J; Goemaere E; Coetzee D; Maartens G
    AIDS; 2010 Feb; 24(4):563-72. PubMed ID: 20057311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antiretroviral treatment programme monitoring in Eastern Cape, South Africa.
    Kaposhi BM; Mqoqi N; Schopflocher D
    Health Policy Plan; 2015 Jun; 30(5):547-54. PubMed ID: 24939706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of transmitted resistance to antiretroviral drug classes among young children in the Western Cape Province of South Africa.
    van Zyl GU; Cotton MF; Claassen M; Abrahams C; Preiser W
    Pediatr Infect Dis J; 2010 Apr; 29(4):370-1. PubMed ID: 19935449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda.
    Muhamadi L; Nsabagasani X; Tumwesigye MN; Wabwire-Mangen F; Ekström AM; Peterson S; Pariyo G
    Health Policy; 2010 Oct; 97(2-3):187-94. PubMed ID: 20615573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of risk behavior among people living with HIV Initiating and waiting to start antiretroviral therapy in Cape Town South Africa.
    Eisele TP; Mathews C; Chopra M; Brown L; Silvestre E; Daries V; Kendall C
    AIDS Behav; 2008 Jul; 12(4):570-7. PubMed ID: 17636372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in Uganda.
    Ndagije H; Nambasa V; Namagala E; Nassali H; Kajungu D; Sematiko G; Olsson S; Pal S
    Drug Saf; 2015 Apr; 38(4):395-408. PubMed ID: 25749663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.